BioLight Life Sciences Ltd. (TLV:BOLT)
Israel · Delayed Price · Currency is ILS · Price in ILA 290.20
-10.00 (-3.33%)
Sep 8, 2026, 5:24 PM IDT
BioLight Life Sciences Market Cap
BioLight Life Sciences has a market cap or net worth of 26.35 million as of September 11, 2026. Its market cap has increased by 4.61% in one year.
Market Cap
26.35M
Enterprise Value
14.33M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
290.20
ChartMarket Cap Chart
Since January 11, 2006, BioLight Life Sciences's market cap has decreased from 47.74M to 26.35M, a decrease of -44.81%. That is a compound annual growth rate of -2.83%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 8, 2026 | 26.35M | -17.22% |
| Dec 31, 2025 | 31.83M | 25.69% |
| Dec 31, 2024 | 25.32M | 4.99% |
| Dec 31, 2023 | 24.12M | -19.99% |
| Dec 29, 2022 | 30.15M | -42.70% |
| Dec 30, 2021 | 52.62M | 53.43% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Bonus BioGroup | 202.09M |
| Matricelf | 80.79M |
| Clal Biotechnology Industries | 40.31M |
| BioLineRx | 34.07M |
| XTL Biopharmaceuticals | 25.16M |
| Evogene | 23.78M |
| Purple Biotech | 18.65M |
| Can-Fite BioPharma | 14.84M |